Endovasc, Inc. (Endovasc) is a business development company. The Company assists medical device companies that do not have ready access to capital through conventional financial channels. The Company provides capital and managerial expertise to these companies for the development, marketing and licensing biopharmaceutical products, particularly liposomal drug delivery methods, for the human healthcare industry. Through one of its portfolio companies, Liprostin, Inc., Endovasc develops liposomes. The Company�s products include Liprostin, PROStent, Biodegradable Vascular Stents, Biodegradable Ureteral and Prostatic Stents and Endothil-CR.